James J Biagi

7PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Apr 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

|Nov 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.

Rémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé

|Jan 19, 2023
Impact of an Accelerated Diagnostic Assessment Program on the Timeliness of Cancer Diagnosis and Treatment.

Adrienn N Bourkas, Alexandre Menard, Emidio Tarulli

|Oct 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.

Sheron Perera, Gun Ho Jang, Yifan Wang

Pageof 2

Frequent Collaborators

4 joint publications

Rémy Nicolle

4 joint publications

Thierry Conroy

4 joint publications

Jérome Cros

3 joint publications

Nelson J Dusetti